PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-58.66%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-57.94%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-108.34%
Negative EBIT growth while 6617.T is at 141.12%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-113.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-105.56%
Negative net income growth while 6617.T stands at 108.68%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-105.56%
Negative EPS growth while 6617.T is at 108.72%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-105.56%
Negative diluted EPS growth while 6617.T is at 108.72%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.70%
Positive 10Y revenue/share CAGR while 6617.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
90.15%
Positive 5Y CAGR while 6617.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
18.56%
3Y revenue/share CAGR above 1.5x 6617.T's 1.36%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.57%
Net income/share CAGR above 1.5x 6617.T's 34.56% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
77.57%
5Y net income/share CAGR above 1.5x 6617.T's 1.94%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
76.53%
Below 50% of 6617.T's 610.64%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
406.76%
10Y equity/share CAGR above 1.5x 6617.T's 5.73%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
64.03%
5Y equity/share CAGR above 1.5x 6617.T's 6.94%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
17.57%
3Y equity/share CAGR above 1.5x 6617.T's 3.55%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.79%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-7.37%
Inventory is declining while 6617.T stands at 5.72%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.91%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.44%
50-75% of 6617.T's 0.81%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-17.47%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-19.85%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
2.44%
SG&A declining or stable vs. 6617.T's 93.99%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.